Approaching a new era for hepatitis C virus therapy: inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase
- 22 February 2003
- journal article
- review article
- Published by Elsevier in Antiviral Research
- Vol. 58 (1) , 1-16
- https://doi.org/10.1016/s0166-3542(03)00028-7
Abstract
No abstract availableKeywords
This publication has 121 references indexed in Scilit:
- On the size of the active site in proteases. I. PapainPublished by Elsevier ,2005
- Future therapy of hepatitis CHepatology, 2002
- The Hepatitis C Virus (HCV)–Trimera Mouse: A Model for Evaluation of Agents against HCVThe Journal of Infectious Diseases, 2002
- Sequences in the 5′ Nontranslated Region of Hepatitis C Virus Required for RNA ReplicationJournal of Virology, 2001
- Recent advances in the molecular biology of hepatitis C virusJournal of Molecular Biology, 2001
- Solution structure and dynamics of the single-chain hepatitis C virus NS3 protease NS4A cofactor complexJournal of Molecular Biology, 2001
- The solution structure of the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein provides new insights into its activation and catalytic mechanismJournal of Molecular Biology, 1999
- Binding of amino acid side-chains to S 1 cavities of serine proteinases 1 1Edited by R. HuberJournal of Molecular Biology, 1997
- A Zinc Binding Site in Viral Serine ProteinasesBiochemistry, 1996
- A Novel Sequence Found at the 3′-Terminus of Hepatitis C Virus GenomeBiochemical and Biophysical Research Communications, 1995